Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through two segments: Consumer Operations and Drug Development. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. Flex Pharma was founded by Christoph Westphal and Jennifer M. Cermak  on February 26, 2014 and is headquartered in Boston, MA.
